Bioventus (BVS) Interest & Investment Income (2020 - 2026)

Bioventus (BVS) has reported Interest & Investment Income for 7 consecutive years, with -$4.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Interest & Investment Income rose 45.72% year-over-year to -$4.1 million; the trailing twelve-month figure through Jun 2026 stood at -$19.9 million (up 40.72% YoY), and the FY2025 full-year result was -$26.5 million, up 31.72% from the prior year.
• Interest & Investment Income rose to -$4.1 million in Q2 2026 per BVS's latest filing, from -$4.3 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $1.5 million in Q2 2022 and bottomed at -$10.6 million in Q3 2023.
• Historically, Interest & Investment Income has averaged -$7.0 million across 5 years, with a median of -$7.5 million in 2025.
• The sharpest annual moves came in 2023 and 2026: Interest & Investment Income tumbled 725.42% in 2023, then jumped 45.72% in 2026.
• Over 5 years, Interest & Investment Income stood at -$7.4 million in 2022, then plunged by 39.13% to -$10.3 million in 2023, then increased by 12.48% to -$9.0 million in 2024, then soared by 41.02% to -$5.3 million in 2025, then gained by 23.33% to -$4.1 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered -$4.1 million, -$4.3 million, and -$5.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.